300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Financial Services
Construction
Mobile
Marketplace
Retail
Film
Payments
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Seychelles
Paraguay
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Bangladesh
Cyprus
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Hungary
Italy
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology VC Funds & Investors in Europe (November 2026)

The most active venture capital funds investing in Europe Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Europe Biotechnology startup companies. Find investors to raise a Seed, Series A or Venture - Series Unknown round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
SOSV
VC Fund
181 United States, China, Canada Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software $25k–$5M
Bpifrance
VC Fund
131 France, United States, Switzerland Seed, Venture - Series Unknown, Series A Software, Health Care, Biotechnology $752k–$34M
HTGF (High-Tech Gruenderfonds)
VC Fund
93 Germany, Switzerland, United States Seed, Series A, Venture - Series Unknown Software, Biotechnology, Health Care $680k–$31M
Sofinnova Partners
VC Fund
84 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $7M–$105M
UK Innovation & Science Seed Fund
VC Fund
70 United Kingdom, United States Seed, Venture - Series Unknown Biotechnology, Health Care, Medical $512k–$6.7M
Parkwalk Advisors
VC Fund
68 United Kingdom, United States, Philippines Seed, Series A, Series B Biotechnology, Health Care, Software $991k–$44M
Scottish Enterprise
VC Fund
65 United Kingdom, United States, Switzerland Grant, Seed, Venture - Series Unknown Biotechnology, Software, Health Care $119k–$6.3M
Novo Holdings
VC Fund
59 United States, Denmark, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $9.5M–$135M
Future Planet Capital
VC Fund
57 United Kingdom, United States, Singapore Seed, Series A Biotechnology, Health Care, Software $482k–$20M
SFC Capital
VC Fund
53 United Kingdom, United States, Ireland Seed, Pre-Seed, Venture - Series Unknown Software, Artificial Intelligence, Information Technology $125k–$2.5M
Oxford Science Enterprises
VC Fund
53 United Kingdom, United States, Finland Seed, Series A, Series B Health Care, Biotechnology, Medical $1.3M–$168M
Seventure Partners
VC Fund
47 France, United States, Germany Series A, Series B, Seed Biotechnology, Software, Health Care $1.1M–$63M
Enterprise Ireland
VC Fund
47 Ireland, United States, United Kingdom Seed, Venture - Series Unknown, Grant Software, Health Care, Information Technology $26k–$8.2M
Kurma Partners
VC Fund
43 France, Switzerland, The Netherlands Series A, Seed, Series B Health Care, Biotechnology, Pharmaceutical $2.8M–$98M
Scottish Investment Bank
VC Fund
42 United Kingdom, United States, France Venture - Series Unknown, Seed, Series A Software, Biotechnology, Information Technology $179k–$7.5M
Entrepreneurs First
VC Fund
40 United Kingdom, Singapore, United States Seed, Pre-Seed, Series A Artificial Intelligence, Software, Machine Learning $54k–$41M
Inveready
VC Fund
38 Spain, United States, France Seed, Venture - Series Unknown, Debt Financing Software, Biotechnology, Health Care $400k–$6.5M
Almi Invest
VC Fund
37 Sweden, Norway, United States Venture - Series Unknown, Seed Software, Health Care, Manufacturing $226k–$3.5M
Oxford Technology Management
VC Fund
37 United Kingdom, United States Seed, Series A Biotechnology, Health Care, Software $41k–$8.5M
Boehringer Ingelheim Venture Fund
VC Fund
36 United States, Germany, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $1.8M–$50M
Portugal Ventures
VC Fund
34 Portugal, United States, United Kingdom Seed, Venture - Series Unknown, Pre-Seed Software, Information Technology, Health Care $107k–$3.6M
O2h Ventures
VC Fund
33 United Kingdom, Hungary Seed, Venture - Series Unknown, Series A Biotechnology, Health Care, Pharmaceutical $603k–$25M
IP Group
VC Fund
33 United Kingdom, United States, Australia Seed, Series A, Series B Biotechnology, Health Care, Software $44k–$68M
Centre for the Development of Industrial Technology (CDTI)
VC Fund
32 Spain, United States, United Kingdom Grant, Seed, Venture - Series Unknown Biotechnology, Health Care, Software $167k–$26M
Mercia Fund Managers
VC Fund
32 United Kingdom, United States, Hungary Seed, Venture - Series Unknown, Series A Software, Health Care, Biotechnology $233k–$14M
BioInnovation Institute
VC Fund
31 Denmark, Germany, Switzerland Convertible Note, Pre-Seed, Seed Biotechnology, Medical, Health Care $495k–$5.2M
SOSV SF & NY (Fka IndieBio)
VC Fund
30 United States, United Kingdom, Canada Seed, Pre-Seed, Convertible Note Biotechnology, Health Care, Medical $50k–$5M
GO CAPITAL
VC Fund
29 France, Canada, Israel Seed, Venture - Series Unknown, Series A Software, Biotechnology, Health Care $549k–$13M
Chalmers Ventures AB
VC Fund
29 Sweden, United States Pre-Seed, Seed, Venture - Series Unknown Software, Biotechnology, Information Technology $5.8k–$3.5M
Business Growth Fund
VC Fund
29 United Kingdom, Ireland, United States Venture - Series Unknown, Private Equity, Series A Software, Manufacturing, Information Technology $3.4M–$22M
Forbion Capital Partners
VC Fund
29 United States, United Kingdom, The Netherlands Series A, Series B, Series C Biotechnology, Health Care, Medical $16M–$180M
Northstar Ventures
VC Fund
28 United Kingdom, United States, Indonesia Seed, Venture - Series Unknown, Series A Software, Information Technology, Health Care $45k–$10M
Catapult Ventures
VC Fund
28 United Kingdom, United States, Israel Seed, Venture - Series Unknown Health Care, Biotechnology, Medical $150k–$5.6M
European Investment Bank
VC Fund
27 France, Germany, Spain Debt Financing, Post-IPO Debt, Venture - Series Unknown Energy, Biotechnology, Health Care $8.7M–$587M
Development Bank of Wales
VC Fund
27 United Kingdom, Australia, United States Seed, Debt Financing, Venture - Series Unknown Software, Manufacturing, Health Care $19k–$5.9M
Epidarex Capital
VC Fund
27 United Kingdom, United States, Germany Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $551k–$48M
Meusinvest (Noshaq)
VC Fund
27 Belgium, France, Germany Series A, Seed, Venture - Series Unknown Biotechnology, Health Care, Medical $159k–$16M
Idinvest Partners
VC Fund
26 France, United States, Germany Series A, Series B, Venture - Series Unknown Software, Health Care, Biotechnology $2.2M–$66M
Karista
VC Fund
26 France, United States, Finland Seed, Series A, Series B Software, Biotechnology, Health Care $713k–$33M
Syncona Partners LLP
VC Fund
25 United Kingdom, United States, Switzerland Series A, Series B, Seed Biotechnology, Medical, Health Care $1.9M–$156M
M Ventures
VC Fund
25 United States, United Kingdom, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.4M–$100M
Elaia
VC Fund
25 France, United States, Spain Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $1.1M–$50M
Octopus Ventures
VC Fund
24 United Kingdom, United States, Germany Series A, Seed, Series B Software, Artificial Intelligence, Health Care $1.9M–$43M
Kelvin Capital
VC Fund
24 United Kingdom, United States Seed, Venture - Series Unknown Health Care, Biotechnology, Manufacturing $167k–$4.4M
PMV
VC Fund
24 Belgium, United States, The Netherlands Seed, Series A, Series B Software, Biotechnology, Health Care $1M–$43M
CDP Venture Capital
VC Fund
24 Italy, United States, Switzerland Seed, Series A, Venture - Series Unknown Software, Artificial Intelligence, Health Care $483k–$23M
Omnes Capital
VC Fund
24 France, Germany, United States Series A, Series B, Venture - Series Unknown Biotechnology, Software, Health Care $2.1M–$67M
Archangels
VC Fund
24 United Kingdom, United States Venture - Series Unknown, Seed Software, Health Care, Biotechnology $795k–$6.6M
Invivo Capital Partners
VC Fund
23 Spain, France, Belgium Seed, Series A, Venture - Series Unknown Biotechnology, Pharmaceutical, Health Care $1.6M–$70M
AdBio partners
VC Fund
22 France, Spain, Belgium Seed, Series A, Venture - Series Unknown Biotechnology, Health Care, Pharmaceutical $2.2M–$37M
Access all 50 VC funds in Europe Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

SOSV
VC Fund · Princeton, New Jersey, United States · 181 investments in Europe Biotechnology startups

SOSV offers pre-seed capital and follow-on financial support to startups focusing on deep technology and scientific innovation. Founders utilize purpose-built laboratory facilities and engineering spaces to accelerate product development and testing. The firm facilitates connections between entrepreneurs and a network of investors through structured matchmaking events and technology summits.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 3821
  • Round size: Seed $125k–$5M; Pre-Seed $25k–$1.5M; Convertible Note $50k–$3.6M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely still investing — raised $306M in 2023

Portfolio highlights

  • Halla — Halla Intelligence is a digital solution that leverages over 100 billion shopper and product data points to recommend and promote what grocery items.
  • Verdex Technologies — Verdex Technologies is an advanced materials platform technology that uses nanofibers to disrupt industries. Verdex doesn't just compete, it innovates and disrupts.
  • Samphire Neuroscience — Samphire Neuroscience builds clinically validated neurotechnology to support women across their lives. Our wearable devices, Nettle™ and Lutea™, are built on the same underlying brain-stimulation technology, targeting neural pathways involved in pain, mood, stress, and sleep regulation. - Lutea™ is available globally as a wellness device. Itstimulates the same regions of the brain to support stress regulation, sleep, and recovery - key drivers of readiness and long-term performance - allowing athletes and teams to move beyond wellbeing education alone to practical, evidence-based intervention. - Nettle™ is a CE-marked (EU and UK regulated), drug- and hormone-free device that has been clinically shown to improve pain, mood, functionality, and the ability to train during the menstrual cycle, with measurable benefits after one month of use - supporting athletes to maintain training intensity and movement quality during their period. - The Samphire App is the platform controlling all Samphire hardware products with the use of CycleSync™ AI technology: the only one of its kind to support personalized neurotechnology use for women.
Show all investments...

Bpifrance
VC Fund · Maisons-alfort, Ile-de-France, France · 131 investments in Europe Biotechnology startups

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: France, United States, Switzerland

Investor stats

  • Total investments: 1745
  • Round size: Seed $752k–$6.1M; Series A $2.6M–$34M; Venture - Series Unknown $1.1M–$32M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely actively investing — fresh fund, raised $27M in 2025

Portfolio highlights

  • Proteor — Proteor offers a complete range of high quality products and services to the O&P world, through more than 60 clinics.
  • Advicenne — Specialty pharmaceutical company focused on the development of pediatric friendly therapeutics for the treatment of orphan renal diseases and neurology.
  • BiPER Therapeutics — BiPER Therapeutics is a biotech company to develop and commercializes novel therapeutics.
Show all investments...

HTGF (High-Tech Gruenderfonds)
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 93 investments in Europe Biotechnology startups

High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in various sectors.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 851
  • Round size: Seed $680k–$6.5M; Series A $3M–$31M; Venture - Series Unknown $911k–$12M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely still investing — raised $515M in 2022

Portfolio highlights

  • Extoll — EXTOLL, a leader in high-speed, ultra-low power SerDes and Chiplet connectivity, offers semiconductor IP with the smallest footprints and highest PPA. Serving global ASIC, SoC, and Chiplet markets, our portfolio includes tailored NoC (Network-on-Chip) and Die-to-Die solutions. EXTOLL drives innovation, enabling successful migration into the Chiplet Age.
  • Selfapy — Selfapy offers a therapy support tool that helps recognize negative patterns of thought and train new behavior. Selfapy is your guided, self-help online course against depression with a personal psychologist as a companion.
  • BlueID GmbH — Smart locks for professionals. BlueID delivers flexible, secure and convenient smart locks for all doors in and around your office.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 84 investments in Europe Biotechnology startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 360
  • Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fresh fund, raised $755M in 2025

Portfolio highlights

  • Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
  • IMIO — Improve efficiency across the crop nutrient cycle. IMIO natural microbial products reliably increase nutrient availability and reduce tillage.
  • DMC Biotechnologies — Transforming How the World Makes Chemicals
Show all investments...

UK Innovation & Science Seed Fund
VC Fund · Harwell, Oxfordshire, United Kingdom · 70 investments in Europe Biotechnology startups

UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Venture - Series Unknown
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 151
  • Round size: Seed $512k–$5.9M; Venture - Series Unknown $1M–$6.7M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
  • StandardX — StandardX is a deep-tech company building the isotope refinery powered by a scalable, compact particle accelerator platform.
  • SILVIA BIO — SilVia Bio develops technologies to analyze and optimize mammalian cell factories used in biomanufacturing. The company focuses on identifying critical parameters that limit bioproduction yield and product quality in cell systems such as CHO and HEK cells. Its platform provides cell profiling services that generate interpretable data on manufacturing-relevant bottlenecks. Based on these insights, SilVia Bio designs and supplies precision media additives formulated to address specific rate-limiting cellular processes. The offerings are intended for biopharmaceutical and biomanufacturing teams seeking to improve titre, cell performance, and consistency in production processes. SilVia Bio also collaborates with industrial partners to apply its platform within real manufacturing environments.
Show all investments...

Parkwalk Advisors
VC Fund · London, England, United Kingdom · 68 investments in Europe Biotechnology startups, 11 in the past 12 months

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009, anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth. Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Philippines

Investor stats

  • Total investments: 356
  • Round size: Seed $991k–$4.9M; Series A $1.6M–$14M; Series B $1.7M–$44M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • Adsilico — Explore how virtual populations and in silico trials help medical device teams understand variation and build stronger evidence.
  • Illumion — Illumion develops high-throughput optical tools to accelerate battery material development
  • MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
Show all investments...

Scottish Enterprise
VC Fund · Glasgow, Glasgow City, United Kingdom · 65 investments in Europe Biotechnology startups, 36 in the past 12 months

Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Grant, Seed, Venture - Series Unknown
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 410
  • Round size: Seed $406k–$4.3M; Grant $119k–$5.3M; Venture - Series Unknown $566k–$6.3M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • GLORIAH — Explore plant-based intimate hydration oils, water-based personal gels, fragrance roll-ons and product sets designed for simple everyday routines.
  • SolarSub — SolarSub is an environmental firm that offers floating solar cooling system.
  • INEOS O&P USA — INEOS O&P USA specializes in producing raw materials that are essential in the manufacture of a wide variety of goods under various sectors.
Show all investments...

Novo Holdings
VC Fund · Hellerup, Hovedstaden, Denmark · 59 investments in Europe Biotechnology startups

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 415
  • Round size: Series A $9.5M–$133M; Series B $15M–$135M; Series C $35M–$118M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $165M in 2018

Portfolio highlights

  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
  • SCHOTT Poonawalla — SCHOTT Poonawalla is a manufacturer of pharmaceutical containers, made of neutral glass tubing. The company provides parenteral packaging systems crafted from tubular glass, serving the pharmaceutical industry with a broad range of products including vials, pre-fillable syringes, ampoules, and cartridges.
  • Vantia Therapeutics — Vantia Therapeutics is an emerging pharmaceutical company developing novel, small molecule drugs targeting large areas of unmet medical need. Its strong clinical pipeline includes VA106483 for nocturia and VA111913 for dysmenorrhoea, which directly target indications that together affect many millions of people, are poorly treated and representbillion dollar markets. Vantia's strategy is to develop its proprietary drug candidates through Phase II clinical testing and then commercialise through partnerships. The Company was founded in 2008 and is backed by specialist life science investors Novo A/S, SV Life Sciences and MVM Life Science Partners.
Show all investments...

Future Planet Capital
VC Fund · London, England, United Kingdom · 57 investments in Europe Biotechnology startups

Brilliant Ideas. Brilliant People. Brilliant Minds.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Singapore

Investor stats

  • Total investments: 313
  • Round size: Seed $482k–$5.1M; Series A $1.4M–$20M
  • Lead/follow: 4% lead, 96% follow
  • Last fund: Likely still investing — raised $23M in 2022

Portfolio highlights

  • Unloq AI — Unloq is a decision intelligence platform that helps businesses understand why a choice makes sense, what actions to take, and whether they deliver results.
  • Nourished — At Nourished we create innovative. personalised nutrition stacks that are truly unique to you. Vegan, waste-free and always made to order.
  • K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
Show all investments...

SFC Capital
VC Fund · London, England, United Kingdom · 53 investments in Europe Biotechnology startups, 56 in the past 12 months

Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 804
  • Round size: Seed $125k–$1.9M; Pre-Seed $170k–$846k; Venture - Series Unknown $201k–$2.5M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — raised $1.9M in 2019

Portfolio highlights

  • Obsero — Obsero is an AI search intelligence platform and consultancy designed for marketing and communications teams. The platform tracks, measures, and optimizes how brands surface, get cited, and are recommended across Large Language Models (LLMs) and AI search assistants.
  • Surghive — Surghive provides a platform-agnostic virtual reality (VR) and AI-enabled training intelligence platform designed to solve the robotic surgical training bottleneck in healthcare.
  • Overtone — Decibels Audio Ltd. is a London-based technology company that designs and manufactures Overtone, a specialized audio device engineered for personalized sound enhancement. Crafted from bio-acetate and titanium, the device utilizes a finely tuned sound engine developed alongside audiological experts to improve speech clarity and support everyday hearing experiences.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Oxford Science Enterprises
VC Fund · Oxford, Oxfordshire, United Kingdom · 53 investments in Europe Biotechnology startups

Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Finland

Investor stats

  • Total investments: 210
  • Round size: Seed $1.3M–$12M; Series A $6.3M–$45M; Series B $9.1M–$168M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — raised $299M in 2022

Portfolio highlights

  • Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.
  • OMass Therapeutics — OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

Seventure Partners
VC Fund · Paris, Ile-de-France, France · 47 investments in Europe Biotechnology startups

Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion. Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion under management as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations. Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors. The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 281
  • Round size: Seed $1.1M–$4.7M; Series A $3.3M–$24M; Series B $3.3M–$63M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Flexvelop — Flexvelop is a fintech transforming the way businesses finance essential business equipment. "Flexing" is an innovative combination of leasing, renting and bank-financing terms offering a kind of Hardware-as-a-Service solution. Embedded as a payment solution, partnered manufacturers, vendors and brands are actively offering"Flexing" to their b2b customers for financing new business equipment right at the point of sale and in online shops. Flexvelop is operating in the verticals of office-it, hospitality equipment, medical devices or fitness equipment throughout Germany. Well-known manufacturers like Lenovo, WMF, or LaMarzocco are using Flexing openly or as a white-label solution. SMB customers flex equipment to grow flexibly without the usual investment risk – saving liquidity, tax and a clean balance sheet. Flexvelop is using its patented in-house financing technology, promoting a more sustainable circular economy in the same time. Flexing becomes the new standard for business equipment procurement for SMBs throughout Germany, Europe and beyond.
  • Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
  • Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
Show all investments...

Enterprise Ireland
VC Fund · Dublin, Dublin, Ireland · 47 investments in Europe Biotechnology startups

Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Venture - Series Unknown, Grant
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 895
  • Round size: Seed $399k–$3.2M; Grant $26k–$5.5M; Venture - Series Unknown $560k–$8.2M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $1.2M in 2021

Portfolio highlights

  • Foodcloud — We connect businesses that have surplus food with Charities and Community Groups that need it.
  • Amethyst Care — Amethyst Care is a startup that creates an AI-powered voice assistant for those with mobility difficulties.
  • EstateMin — EstateMin provides software for law firms handling estate planning, trust administration, probate, and estate administration. Its platform supports client intake, case workflows, document organization, asset and liability tracking, and case progress visibility through a centralized dashboard. A client portal lets clients and executors submit information and documents. The platform also offers AI-supported case review and integrates with Clio.
Show all investments...

Kurma Partners
VC Fund · Paris, Ile-de-France, France · 43 investments in Europe Biotechnology startups

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovations in Europe, particularly through links with many institutes. research and prestigious hospitals.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Pharmaceutical
  • Stage:Series A, Seed, Series B
  • Geography: France, Switzerland, The Netherlands

Investor stats

  • Total investments: 146
  • Round size: Seed $2.8M–$14M; Series A $3.9M–$98M; Series B $12M–$72M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — raised $236M in 2024

Portfolio highlights

  • RougeTx — RougeTx is a Netherlands-based biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction. Its lead candidate, RTX-001, targets hereditary haemorrhagic telangiectasia (HHT), an inherited disorder involving fragile blood vessels and recurrent bleeding.
  • AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
  • Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
Show all investments...

Scottish Investment Bank
VC Fund · Glasgow, Glasgow City, United Kingdom · 42 investments in Europe Biotechnology startups

Speak with our team, who can help you find sources of finance, engage with funders and secure investment to grow your business.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Venture - Series Unknown, Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 314
  • Round size: Seed $331k–$3.2M; Series A $1.7M–$7.5M; Venture - Series Unknown $179k–$4.1M
  • Lead/follow: 12% lead, 88% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Corvidae — Corvidae is a software company that provides data analysts, digital marketing, e commerce, and paid media solutions.
  • IOTech — Discover IOTech Systems. Deploy, manage, and scale AI-driven, data-rich industrial systems at the edge with our open edge data platform.
  • RoslinCT — We are the prefered global partner for cell and gene therapy solutions. With our wealth of expertise and infrastructure, we can support you at every step of your advanced therapy journey.
Show all investments...

Entrepreneurs First
VC Fund · London, England, United Kingdom · 40 investments in Europe Biotechnology startups

We turn exceptional individuals into funded founders. We back you first, then give you a bridge to Silicon Valley.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, Singapore, United States

Investor stats

  • Total investments: 485
  • Round size: Seed $54k–$6.7M; Pre-Seed $55k–$2.7M; Series A $5.1M–$41M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: Likely actively investing — fresh fund, raised $133M in 2026

Portfolio highlights

  • ByteAsk — Derisk your AI agents
  • Sourcepulse — Your early warning system for software delivery (YC S23)
  • Open Cosmos — Open Cosmos design, build and operate space missions, providing straightforward access to high quality satellite data and insights on a global scale.
Show all investments...

Inveready
VC Fund · Barcelona, Catalonia, Spain · 38 investments in Europe Biotechnology startups, 12 in the past 12 months

Inveready is a leading Spanish financial services firm focused on investment solutions and wealth management.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Venture - Series Unknown, Debt Financing
  • Geography: Spain, United States, France

Investor stats

  • Total investments: 291
  • Round size: Seed $400k–$4.7M; Debt Financing $1.2M–$6.5M; Venture - Series Unknown $594k–$5.7M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely still investing — raised $63M in 2024

Portfolio highlights

  • Mirai RiskTech — AI-driven balance sheet management for banks: ALM and liquidity, FTP, and regulatory reporting on one data model.
  • Blinker — Blinker specializes in the wholesale of hardware.
  • Fastbase Solutions — Fastbase is to be the platform in cancer diagnostics, bringing precision to cancer patient treatment. This will enable solution of the current problems, which lie in precisely targeting therapies to disease drivers. Fastbase provides a fast and efficient platform technology to measure drug target function. The benefits of precision medicine thatcan be provided by Fastbase would be to deliver treatment to patients selected to respond to therapy, stop the treatment of patients who will not respond, improve patient outcomes and quality of life and also reduce drug costs. Fastbase will be a major player for collaborative opportunities with European Health system.
Show all investments...

Almi Invest
VC Fund · Stockholm, Stockholms Lan, Sweden · 37 investments in Europe Biotechnology startups

Almi Invest is Sweden’s most active early-stage venture capital firm, investing in scalable startups across Sustainability, Industry, Tech, and Life Science. We invest from pre-seed to Series A, always co-investing with independent private investors to accelerate innovation and long-term success. Our portfolio spans sustainable solutions, industrial innovation, deep tech, SaaS, and life science, supporting startups that drive economic and environmental progress. With €430 million under management and over 1,000 investments since 2009, we have backed leading companies like MIPS, Tobii, and Neo4j, with notable exits to Google, Apple, Microsoft, and Qlik. Beyond capital, we offer engaged ownership, providing strategic guidance, active board participation, and access to an extensive investor network. Almi Invest is part of the Almi Group and is funded by the European Regional Development Fund, Almi AB, and regional partners.

Show more...

Investment focus

  • Industry: Software, Health Care, Manufacturing
  • Stage:Venture - Series Unknown, Seed
  • Geography: Sweden, Norway, United States

Investor stats

  • Total investments: 600
  • Round size: Seed $226k–$2.2M; Venture - Series Unknown $338k–$3.5M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — raised $64M in 2024

Portfolio highlights

  • Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
  • Indevex AB — Indevex is a science-based and privately owned biotech company from Sweden. A natural and reliable partner, providing evidence based natural nutrition concepts based on the patented NGC™ Formula.
  • Xaga Surgical — Xaga Surgical aims to minimize the risk of infections by inventing safer medical needles.
Show all investments...

Oxford Technology Management
VC Fund · Oxford, Oxfordshire, United Kingdom · 37 investments in Europe Biotechnology startups

Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 113
  • Round size: Seed $41k–$2.2M; Series A $786k–$8.5M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: May invest from a new fund soon — last raise in 2012

Portfolio highlights

  • OrganOx — OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford.
  • HydRegen — HydRegen is a biotechnology company that provides sustainable solutions for chemical manufacturing. HydRegen was founded in 2020 and was headquartered in Oxford, United Kingdom.
  • Metacarpal — Metacarpal design upper-limb prosthetics without compromise. We aim to make the most robust, functional hand prosthesis that people love wearing because it works so effectively and looks so beautiful. Be proud to show your artificial side!
Show all investments...

Boehringer Ingelheim Venture Fund
VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 36 investments in Europe Biotechnology startups, 6 in the past 12 months

Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 108
  • Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: May invest from a new fund soon — raised $250M in 2018

Portfolio highlights

  • Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
  • smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
  • Cloverleaf Bio — Cloverleaf Bio | Developing a new class of RNA therapeutics to revolutionize cancer therapy.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Portugal Ventures
VC Fund · Porto, Lisboa, Portugal · 34 investments in Europe Biotechnology startups

Verticals:Enterprise, SaaS, Security, Networks, AI, VR/AR, Marketplace, Blockchain, Internet of Things, New materials, Electronics, Robotics, Cleantech, Agrotech, Seatech, Therapeutics, Digital Health, Diagnostics, Innovative Accommodation, Tourist Entertainment Companies, Tour Operators, Wine, Nautical and Equestrian Tourism, Theme Parks Mobile, Robotics Founded in 2012, Portugal Ventures is a venture capital firm based in Porto, Portugal. The firm is a part of the Banco Português de Fomento group. The firm seeks to invest in pre-seed, seed and series A stages

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: Portugal, United States, United Kingdom

Investor stats

  • Total investments: 409
  • Round size: Seed $121k–$1.9M; Pre-Seed $107k–$796k; Venture - Series Unknown $121k–$3.6M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Fetalix — Fetal-inspired solutions for tissue regeneration
  • Unlockit — Unlockit will offer to public and governmental bodies the guarantee that everything within a real estate transaction is recorded, meaning better industry regulation, more taxes and public fees collected, and less overall fraud and money laundering activities.
  • Outgoing — A ticketing tool that allows organizers to sell tickets directly on WhatsApp and Instagram. Users can purchase tickets through a personalized checkout process entirely within the chat, without registration or redirects. It also offers customer support that answers questions in real time.
Show all investments...

O2h Ventures
VC Fund · 33 investments in Europe Biotechnology startups

Transforming UK biotech breakthroughs into impact. o2h Ventures offers SEIS/EIS and growth-stage funds to back visionary teams from seed to clinical success.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: United Kingdom, Hungary

Investor stats

  • Total investments: 60
  • Round size: Seed $603k–$7.3M; Series A $1.9M–$25M; Venture - Series Unknown $1.1M–$2.9M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Healx — Healx is a mission-driven technology company pioneering the next wave of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are 7,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AItechnology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this huge unmet need and have unprecedented patient impact. Founded in Cambridge, UK, in 2014 by Dr Tim Guilliams (a Biochemical Engineer and tech entrepreneur) and Dr David Brown (co-inventor of Viagra and former Global Head of Drug Discovery at Roche), Healx has raised $70 million to date. For more information, visit www.healx.io.
  • Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
  • Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
Show all investments...

IP Group
VC Fund · London, England, United Kingdom · 33 investments in Europe Biotechnology startups, 12 in the past 12 months

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and create value out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Australia

Investor stats

  • Total investments: 261
  • Round size: Seed $44k–$5.3M; Series A $2.4M–$30M; Series B $7.9M–$68M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: Likely actively investing — fresh fund, raised $50M in 2026

Portfolio highlights

  • Microbiotica — Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and invivo models.
  • Matter Machine — Matter Machine is an AI-driven materials discovery company that creates technologies that use materials chemistry, machine learning, and automated experimentation to speed up the discovery and optimization of next-generation materials.
  • Mach42 — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
Show all investments...

Centre for the Development of Industrial Technology (CDTI)
VC Fund · Madrid, Madrid, Spain · 32 investments in Europe Biotechnology startups, 26 in the past 12 months

The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national and international levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Grant, Seed, Venture - Series Unknown
  • Geography: Spain, United States, United Kingdom

Investor stats

  • Total investments: 225
  • Round size: Seed $619k–$5.8M; Grant $167k–$15M; Venture - Series Unknown $846k–$26M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • EpiDisease — EpiDisease provides biomedical solutions, epigenetic diagnostic tools, and characterization of new epigenetic drugs. The company was founded in 2014 and based in Paterna, Comunidad Valenciana, Spain.
  • Anaconda BioMed — Anaconda Biomed, headquartered in Barcelona, Spain, is among the world's most innovative early stage medical technology companies. The company was founded by Dr. Ofir Arad and Dr. Marc Ribó in 2015, and is developing the ANCD BRAIN™, a novel 3rd Generation Stented Aspiration Thrombectomy System for the treatment of Acute Ischemic Stroke (AIS).
  • Connecta Therapeutics — Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system. It focuses on the development of a first-in-class drug for the treatment of fragile X syndrome.
Show all investments...

Mercia Fund Managers
VC Fund · Henley In Arden, Warwickshire, United Kingdom · 32 investments in Europe Biotechnology startups

Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: United Kingdom, United States, Hungary

Investor stats

  • Total investments: 158
  • Round size: Seed $233k–$2M; Series A $1.3M–$14M; Venture - Series Unknown $394k–$5.9M
  • Lead/follow: 64% lead, 36% follow
  • Last fund: May invest from a new fund soon — last raise in 2013

Portfolio highlights

  • Ben — Ben is the all-in-one platform for any company to personalise benefits and reward.Our secret? Marrying a modern software (SaaS) platform with per-employee Mastercards and financial infrastructure. That’s how Ben instantly adds employee choice to your existing benefits, unlocks access to hundreds of additional options through Ben Card, all whilesaving you time and money.
  • Distil.ai — Distil.ai is a software platform that helps businesses to understand their customers’ behavior and identify buying signals.
  • MRC Engineering — MRC Engineering Providing a different option to the UK Rail Industry for Telecoms Design. Nationally renowned design specialists who provide extraordinary ...
Show all investments...

BioInnovation Institute
VC Fund · Copenhagen, Hovedstaden, Denmark · 31 investments in Europe Biotechnology startups

BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup's mission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups. BioInnovation Institute was founded in 2018 and is based in Denmark.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Convertible Note, Pre-Seed, Seed
  • Geography: Denmark, Germany, Switzerland

Investor stats

  • Total investments: 93
  • Round size: Seed $532k–$1.8M; Pre-Seed $530k–$5.2M; Convertible Note $495k–$1.6M
  • Lead/follow: 92% lead, 8% follow

Portfolio highlights

  • Visibuilt — Visibuilt develops sustainable, bio-based asphalt binders made from mycelium. Replace fossil bitumen with visiBIT.
  • Agrobiomics — Agrobiomics is a danish Agritech start-up, harnessing the power of soil bacteria and their metabolites as new biostimulants to help crops cope with abiotic stress such as drought.
  • metaLead Therapeutics — metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.
Show all investments...

SOSV SF & NY (Fka IndieBio)
VC Fund · San Francisco, California, United States · 30 investments in Europe Biotechnology startups

IndieBio, re-named SOSV SF and SOSV NY in 2026, are two of SOSV’s three deeply resourced facilities for deep tech founders. The third is SOSV's HAX, in Newark, NJ. SOSV is the most active deep tech venture capital firm globally.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 676
  • Round size: Seed $250k–$5M; Pre-Seed $50k–$525k; Convertible Note $150k–$950k
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • FluoSphera — Fluosphera better predicts the effects of molecules through animal-free microphysiological systems, helping you to discover more efficient drugs with less adverse side effects.
  • Giraffe Bio — Giraffe Bio uses AI and biomolecules to optimize metal extraction, increase yield, and reduce environmental impact. Revolutionizing sustainable mining technology.
  • Transition Metal Solutions — Transition harnesses wild microbial communities to recover copper and other critical metals from low-grade mining resources.
Show all investments...

GO CAPITAL
VC Fund · Rennes, Bretagne, France · 29 investments in Europe Biotechnology startups

GO Capital is an independent management company and a major player in regional Seed and Venture Capital since 2003. With offices in Brittany, Pays de la Loire, Normandy, Centre-Val de Loire and the South of France, GO Capital contributes to the financing of responsible innovation in these regions. With a team of investors with complementary sectoral experience, we have a solid track-record in DeepTech. GO Capital has nearly 400 million euros under management, and mainly finances technology leaders in the digital and healthcare sectors and in the industry of the future.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: France, Canada, Israel

Investor stats

  • Total investments: 144
  • Round size: Seed $549k–$7.1M; Series A $2.1M–$13M; Venture - Series Unknown $723k–$9.5M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely still investing — raised $25M in 2023

Portfolio highlights

  • SoonGo — SoonGo is a SaaS company that helps businesses manage and optimize vehicle fleets and professional mobility using data and AI.
  • Edison IA — Edison IA functions as an artificial intelligence accelerator designed to help small and medium-sized enterprises integrate AI into their business operations. The company provides a structured, multi-phase framework—spanning 30, 60, and 90 days—to guide businesses from initial training to full deployment. It specializes in developing custom, secure AI agents tailored to automate internal processes, analyze data, and optimize specific corporate workflows. Their service includes auditing a company's readiness, training employees, and implementing scalable AI solutions that comply with data privacy standards.
  • NeoXperiences — NeoXperiences develops technological solutions that bring audiences together around fun and interactive experiences.
Show all investments...

Chalmers Ventures AB
VC Fund · Göteborg, Vastra Gotaland, Sweden · 29 investments in Europe Biotechnology startups

We are a leading tech investor & venture builder in the Nordics. Taking deep tech from lab to market.WELCOMEINVESTMENTS

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Pre-Seed, Seed, Venture - Series Unknown
  • Geography: Sweden, United States

Investor stats

  • Total investments: 283
  • Round size: Seed $237k–$2.5M; Pre-Seed $5.8k–$349k; Venture - Series Unknown $357k–$3.5M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
  • Solinide Photonics — Solinide Photonics is a technological company spun out of Chalmers University of Technology. It develops ultra-efficient silicon nitride-based photonic circuits and microcomb technologies.
  • InfiniNode Technologies AB — InfiniNode is a semiconductor IP company that seeks to enable efficient data movement in future compute systems.
Show all investments...

Business Growth Fund
VC Fund · London, England, United Kingdom · 29 investments in Europe Biotechnology startups

BGF is the most active equity investor in the UK and Ireland, providing long-term, minority investment to growing companies.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Venture - Series Unknown, Private Equity, Series A
  • Geography: United Kingdom, Ireland, United States

Investor stats

  • Total investments: 629
  • Round size: Series A $4.1M–$21M; Private Equity $6M–$22M; Venture - Series Unknown $3.4M–$16M
  • Lead/follow: 86% lead, 14% follow
  • Last fund: Likely still investing — raised $97M in 2022

Portfolio highlights

  • Camino — Camino Leisure Holdings is a Spanish bar and restaurant that serves authentic food and wines.
  • OCL Vision — Expert eye care from trusted UK specialists. From laser vision correction to cataract surgery, discover life-changing treatments.
  • Granite Digital — GRANITE is a digital agency with expertise in technology & strategy providing clients with Digital Transformation services including Web Design, Development, SEO, PPC, email marketing and Social Media as well as online software & app development.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Forbion Capital Partners
VC Fund · Naarden, Noord-Holland, The Netherlands · 29 investments in Europe Biotechnology startups

Impacting the future of medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 229
  • Round size: Series A $20M–$180M; Series B $16M–$155M; Series C $22M–$123M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: Likely actively investing — fresh fund, raised $606M in 2026

Portfolio highlights

  • OMass Therapeutics — OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
  • Lisata Therapeutics — Lisata is a clinical-stage pharmaceutical company dedicated to improving lives through the discovery, development, and commercialization of innovative medicines.
Show all investments...

Northstar Ventures
VC Fund · Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom · 28 investments in Europe Biotechnology startups, 9 in the past 12 months

Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: United Kingdom, United States, Indonesia

Investor stats

  • Total investments: 373
  • Round size: Seed $45k–$1.3M; Series A $295k–$10M; Venture - Series Unknown $363k–$3.6M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: Likely still investing — raised $20M in 2024

Portfolio highlights

  • OneClickComply — OneClickComply automates ISO 27001, SOC 2, Cyber Essentials and 240+ standards: evidence from 13,000+ tools, one-click fixes and an in-house audit team.
  • Land Digital — Land Digital is a tech, web design, web creation, content marketing, digital marketing, SEO, and mobile application agency.
  • Magnitude Biosciences — Magnitude Biosciences is a biotechnology firm combine experience in ageing research, the nematode C. elegans and automation.
Show all investments...

Catapult Ventures
VC Fund · Leicester, Leicester, United Kingdom · 28 investments in Europe Biotechnology startups

The team behind Catapult Ventures are among the most experienced venture capital investors in the UK. Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of pounds in revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Venture - Series Unknown
  • Geography: United Kingdom, United States, Israel

Investor stats

  • Total investments: 105
  • Round size: Seed $150k–$5.6M; Venture - Series Unknown $370k–$5M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Path Robotics — We create manufacturing robots that autonomously scan, position, and weld your parts without the need for skilled welders or robot programmers.
  • Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
  • Anello Photonics — Anello Photonics is a technology company developing a silicon photonic optical gyroscope to navigate, position, and motion track autonomous applications in challenging GPS-jammed and spoofed environments. The company's technology portfolio spans over 28 issued patents, and over 44 pending patents, and includes an AI-based sensor fusion engine.It serves the robotics, defense, construction, agriculture, and autonomous vehicles industries.
Show all investments...

European Investment Bank
VC Fund · Luxembourg, Luxembourg, Luxembourg · 27 investments in Europe Biotechnology startups

European Investment Bank operates as the lending institution of the European Union, offering loans, guarantees, and technical expertise to governments, businesses, and financial institutions. The organization focuses on areas such as climate action, digital transformation, housing development, and security-related initiatives. Its activities include funding large-scale infrastructure, supporting technology development, and facilitating access to capital for emerging and established enterprises. The bank also delivers advisory support to structure projects, improve investment readiness, and align initiatives with policy objectives.

Show more...

Investment focus

  • Industry: Energy, Biotechnology, Health Care
  • Stage:Debt Financing, Post-IPO Debt, Venture - Series Unknown
  • Geography: France, Germany, Spain

Investor stats

  • Total investments: 608
  • Round size: Post-IPO Debt $16M–$587M; Debt Financing $16M–$355M; Venture - Series Unknown $8.7M–$110M
  • Lead/follow: 82% lead, 18% follow

Portfolio highlights

  • Impress — Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020.
  • Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
  • Dandara Solar Power SAE — Dandara Solar Power SAE is a special purpose vehicle, established to develop a major renewable energy and storage project in Upper Egypt. The entity oversees the development and operational construction of a 500 MW solar PV plant integrated with a 100 MWh Battery Energy Storage System. All electricity generated by the company is bound to be sold to the industrial manufacturer Misr Aluminum Company under a long term, take or pay power purchase agreement.
Show all investments...

Development Bank of Wales
VC Fund · Cardiff, Cardiff, United Kingdom · 27 investments in Europe Biotechnology startups

Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Health Care
  • Stage:Seed, Debt Financing, Venture - Series Unknown
  • Geography: United Kingdom, Australia, United States

Investor stats

  • Total investments: 301
  • Round size: Seed $327k–$2.5M; Debt Financing $19k–$3.7M; Venture - Series Unknown $383k–$5.9M
  • Lead/follow: 61% lead, 39% follow
  • Last fund: May invest from a new fund soon — raised $27M in 2018

Portfolio highlights

  • Design and Supply — Design and Supply provides products and services primarily for the construction industry, offering Jansen-certified products and British SBD solutions. The company manufactures and supplies items, including steel doors. Additionally, Design and Supply caters to design enthusiasts by offering artwork, fine furniture, antiques, and decor.
  • MeOmics Technology — MeOmics Technology is a biotech company with a focus on improving the diagnosis and treatment of mental health illnesses. The company operates in the manufacturing industry and has a team of 9 employees. The team includes experts in Neuronal Cell Biology and Neuropsychopharmacology. The company's mission is to leverage technology to enhancethe understanding and treatment of mental health conditions.
  • Outlook Expeditions — Outlook Expeditions provide overseas educational expeditions, adventure travel and service-learning projects for schools.
Show all investments...

Epidarex Capital
VC Fund · Bethesda, Maryland, United States · 27 investments in Europe Biotechnology startups

Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, international corporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 53
  • Round size: Seed $551k–$8.5M; Series A $2.6M–$40M; Series B $2.4M–$48M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely actively investing — fresh fund, raised $145M in 2026

Portfolio highlights

  • Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
  • RougeTx — RougeTx is a Netherlands-based biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction. Its lead candidate, RTX-001, targets hereditary haemorrhagic telangiectasia (HHT), an inherited disorder involving fragile blood vessels and recurrent bleeding.
  • Epsilogen — IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.
Show all investments...

Meusinvest (Noshaq)
VC Fund · Liège, Liege, Belgium · 27 investments in Europe Biotechnology startups

Noshaq offers financial services to help businesses develop.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed, Venture - Series Unknown
  • Geography: Belgium, France, Germany

Investor stats

  • Total investments: 82
  • Round size: Seed $159k–$6M; Series A $3.6M–$16M; Venture - Series Unknown $946k–$16M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Le Fourgon — Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
  • Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Show all investments...

Idinvest Partners
VC Fund · Paris, Ile-de-France, France · 26 investments in Europe Biotechnology startups

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primary investments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting. Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 362
  • Round size: Series A $3.4M–$22M; Series B $7.8M–$66M; Venture - Series Unknown $2.2M–$37M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: May invest from a new fund soon — raised $97M in 2021

Portfolio highlights

  • Actility — Actility provides IoT connectivity and solutions to power smart cities and industries.
  • Pretty Simple — Video games studio based in Paris, France. Makers of Criminal Case and Sorcery School.
  • StarTower — StarTower is a resource company built specifically for fully decentralized physical infrastructure and shared interaction. Based on the exclusive RIP encryption technology, StarTower realizes the interactive sharing of multiple resources with zero loss on mobile devices, thereby providing efficient resource transmission for terminal facilities. Itprovides more efficient, secure and reliable solutions in the fields of Internet of Things, smart cities, industrial automation, healthcare, etc.
Show all investments...

Karista
VC Fund · Paris, Ile-de-France, France · 26 investments in Europe Biotechnology startups

Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: France, United States, Finland

Investor stats

  • Total investments: 162
  • Round size: Seed $713k–$6.2M; Series A $1.4M–$23M; Series B $3M–$33M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: Likely still investing — raised $44M in 2021

Portfolio highlights

  • Idylis — Idylis S.A. designs, develops, and markets software solutions for enterprise management. Its products assist in audit and accounting, financial management, documentation, e-mailing, and scheduling applications. The company also offers solutions for commercial applications such as supply chain management, logistics, and inventory management. Inaddition, it provides customer support and consulting services to its clients. The company was incorporated in 2008 and is based in Issy-les-Moulineaux, France.
  • Advestigo — Advestigo S.A., a technology company, provides digital assets protection solutions. It offers theraography technology, which analyses digital content to generate content-based fingerprints; AdvestiCHECK, a software package that allows companies to monitor information technology networks and workstations; and AdvestiGUARD, a software package thatallows companies to monitor communication channels. The company was founded in 2002 and is based in Saint-Cloud, France. As of March 9, 2009, Advestigo S.A. operates as a subsidiary of Hologram Industries SA.
  • Edenwall Technologies — Edenwall is a security vendor of identity-based firewall connection filtering solutions.
Show all investments...

Syncona Partners LLP
VC Fund · London, England, United Kingdom · 25 investments in Europe Biotechnology startups

Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 78
  • Round size: Seed $1.9M–$17M; Series A $13M–$87M; Series B $29M–$156M
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • OMass Therapeutics — OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
  • Re-Aim Therapeutics — Re‑Aim Therapeutics is a UK‑based biotech start‑up developing functional cures for T cell–mediated autoimmune diseases by selectively depleting pathogenic T‑cell subsets. Its lead asset, REA‑001, is a monoclonal antibody designed to potently and precisely eliminate disease‑causing type‑17 T cells, aiming to reset the immune system and achievedurable, treatment‑free remission in multiple autoimmune conditions.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 25 investments in Europe Biotechnology startups

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 190
  • Round size: Seed $2.4M–$24M; Series A $5.8M–$56M; Series B $13M–$100M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Mueon — semiconductor-based systems for AI and hyperscale computing
  • Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
  • iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
Show all investments...

Elaia
VC Fund · Paris, Ile-de-France, France · 25 investments in Europe Biotechnology startups

Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: France, United States, Spain

Investor stats

  • Total investments: 246
  • Round size: Seed $1.1M–$7.6M; Series A $2M–$23M; Series B $4.2M–$50M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely actively investing — fresh fund, raised $154M in 2026

Portfolio highlights

  • Hema.to — Flow cytometry analysis software, re-imagined. From raw FCS and LMD data to finalized report with AI-powered CellStudio.
  • RelaiSanté — RelaiSanté provides a digital coordination platform that connects hospitals with home care providers to manage patient return home. The company offers online tools for hospital teams, home help services, independent nurses and territorial health actors to organize care pathways after hospitalization. RelaiSanté enables secure information sharing, task assignment and monitoring of care arrangements between medical and social care stakeholders. Its products include dedicated interfaces for establishments, home care services and independent professionals. The platform supports teams in structuring discharge processes, reducing fragmentation of communication and clarifying responsibilities. RelaiSanté focuses on improving continuity of care between the healthcare facility and the patient’s home environment.
  • Sim&Cure — Providing Physicians with advanced endovascular treatment solutions for a better Patient Care
Show all investments...

Octopus Ventures
VC Fund · London, England, United Kingdom · 24 investments in Europe Biotechnology startups

We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 455
  • Round size: Seed $1.9M–$12M; Series A $3.4M–$22M; Series B $8M–$43M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: May invest from a new fund soon — raised $108M in 2019

Portfolio highlights

  • Braid — Braid is a telecom and connectivity infrastructure provider that abstracts global mobile networks into programmable APIs and SDKs. The company enables digital brands to embed cellular connectivity directly into their apps, products, or user journeys without dealing with legacy telecom procurement, Capex, or lengthy carrier negotiations.
  • Grasp — Grasp is the world's first AI analyst for finance professionals. Our AI analyst automates company and market research for investment banks, private equity firms, and management consulting firms across the world.
  • Monkey Bizness — Monkey Bizness is the largest provider of indoor family entertainment centres in the UK. Each centre includes a children's soft play area and is designed to provide a safe, clean and fun environment in which parents and children can feel comfortable. Monkey Bizness' centres provide a setting that encourages children to express themselvesthrough creativity and play as well as providing fresh and nutritious food to keep kids happy and healthy.Monkey Bizness currently has centres in eight locations: Lewes, Gosport, Poole, Sheffield, Stevenage, Hull Edinburgh and Glasgow.
Show all investments...

Kelvin Capital
VC Fund · Glasgow, Glasgow City, United Kingdom · 24 investments in Europe Biotechnology startups

Kelvin Capital was founded in 2009 and has since raised a total of over £50million into 28 portfolio companies. We invest venture capital in revenue generating growth companies which have the potential to deliver significant return to their investors. They also invest in companies that require capital to grow their business. For the right company with the right team, Kelvin Capital provides the investment and the support needed to deliver the true potential of their business. The Kelvin Capital team has a combined 30 years experience of working with new businesses and understands both the challenges and opportunities, which will be encountered during the high growth phase. The team has built up extensive networks, which will be made available to assist and support the portfolio businesses. Kelvin Capital will actively promote the portfolio businesses through its website and social media activities raising their awareness and profile. The entire Kelvin Capital team is focused on the success of their portfolio of businesses.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Seed, Venture - Series Unknown
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 113
  • Round size: Seed $167k–$1.9M; Venture - Series Unknown $360k–$4.4M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Kenoteq — Discover Kenoteq, pioneering the sustainable construction revolution with our innovative, ultra low-carbon building materials.
  • Aurora Avionics — Accelerating launch-vehicle development with flexible and modular avionics platforms.
  • Sofant Technologies — Sofant is developing a low cost RF MEMS technology that solves power consumption and heat problems in high frequency phased array antenna systems.
Show all investments...

PMV
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 24 investments in Europe Biotechnology startups, 9 in the past 12 months

Do and dare company

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Belgium, United States, The Netherlands

Investor stats

  • Total investments: 161
  • Round size: Seed $1M–$4.1M; Series A $3M–$40M; Series B $6.6M–$43M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Logibot — Logibot is a European, software-first, hardware-agnostic AI platform that enables logistics and industrial operators to simulate, deploy, and operate human-like robotic labor inside existing intralogistics facilities, without vendor lock-in and without rebuilding the warehouse. Most warehouse automation projects fail because they assume greenfield sites or commit operators to one robot vendor. Logibot takes a different approach. Operators start with Logibot.Data to quantify manual work and score automation feasibility. Logibot.Simulate runs split tests on multiple robot configurations in digital simulation, before any hardware decision is made. Logibot.Train prepares a general vision-language model for specific logistics tasks in five stages. Logibot.Control stages the introduction of robotic labor into live operations. Logibot.Watch provides real-time monitoring, teleoperation, and continuous improvement. Logibot serves 3PLs, CEP operators, postal operators, and industrial logistics teams. Headquartered in Belgium, operating across the EU. NVIDIA Inception member. Beam Berlin portfolio company.
  • Borro — Cashless deposit system
  • SpectaCell — SpectaCell is a Belgian life sciences and biotechnology company that develops next-generation cell therapy analytics.Spun out of a collaborative research effort between imec, VIB, and Ghent University (UGent),
Show all investments...

CDP Venture Capital
VC Fund · Rome, Lazio, Italy · 24 investments in Europe Biotechnology startups

CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Italy, United States, Switzerland

Investor stats

  • Total investments: 305
  • Round size: Seed $483k–$8.1M; Series A $3.3M–$23M; Venture - Series Unknown $652k–$21M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: May invest from a new fund soon — raised $212M in 2021

Portfolio highlights

  • Evja — Evja supports growers in optimizing the management and monitoring of irrigation, nutrition and protection of their crops through the use of OPI, the most advanced system for precision agriculture .
  • Phononic Vibes — The Art of Noise Management START NOW The Art of Noise Management START NOW Phononic Vibes Technology Working with the MetaMaterial technology, Phononic Vibes
  • Tretau — E-mobility is powered by its core - the electric motor. We at Tau are at the very core of the core: the copper winding wire, the magnetic core, the electrical steel.We just make it bet.
Show all investments...

Omnes Capital
VC Fund · Paris, Ile-de-France, France · 24 investments in Europe Biotechnology startups

Omnes Capital takes a unique approach to renewable energy, transforming developers into independent power producers to provide green energy to millions.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: France, Germany, United States

Investor stats

  • Total investments: 189
  • Round size: Series A $4.3M–$41M; Series B $4.4M–$43M; Venture - Series Unknown $2.1M–$67M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely actively investing — fresh fund, raised $132M in 2025

Portfolio highlights

  • Adictiz — Adictiz, a French company founded in 2009 by Charles Christory, develops and publishes social games for the web and mobile phones.With successful brands including “Space Dog” and “What a Stupid Pigeon”, which attract close to 2.5 million players every month, Adictiz has established itself as an expert player in social and mobile gaming.Basedat the EuraTechnologies economic excellence hub in Lille, which is dedicated to serving information and communication technology companies, Adictiz set up Adictiz Studio in late 2011, which specialises in the creation of customised social games for brands. Adictiz Studio was recently selected by Facebook as a PMD (Preferred Marketing Developer).
  • Complix — Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
  • WhiteLab Genomics — Discover WhiteLab Genomics, where AI meets biology to revolutionize genomic medicine. Our innovative platform optimizes drug design for greater safety and efficacy.
Show all investments...

Archangels
VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 24 investments in Europe Biotechnology startups, 8 in the past 12 months

Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Venture - Series Unknown, Seed
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 88
  • Round size: Seed $1.3M–$6.6M; Venture - Series Unknown $795k–$6.3M
  • Lead/follow: 53% lead, 47% follow

Portfolio highlights

  • CSignum — Revolutionising underwater communications with electromagnetic technology for seamless data integration between surface & submerged devices.
  • Corvidae — Corvidae is a software company that provides data analysts, digital marketing, e commerce, and paid media solutions.
  • iGii — Integrated Graphene enable better products with a revolutionary design for manufacture process producing the world's highest quality pure 3D Graphene Foam, Gii.
Show all investments...

Invivo Capital Partners
VC Fund · Barcelona, Catalonia, Spain · 23 investments in Europe Biotechnology startups

Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Spain, France, Belgium

Investor stats

  • Total investments: 35
  • Round size: Seed $1.6M–$13M; Series A $2.2M–$70M; Venture - Series Unknown $3.3M–$8.9M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $44M in 2019

Portfolio highlights

  • Signadori Bio — Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
  • ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
  • Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
Show all investments...

AdBio partners
VC Fund · Paris, Ile-de-France, France · 22 investments in Europe Biotechnology startups

AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: France, Spain, Belgium

Investor stats

  • Total investments: 32
  • Round size: Seed $2.2M–$18M; Series A $18M–$37M; Venture - Series Unknown $2.2M–$16M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: May invest from a new fund soon — raised $116M in 2021

Portfolio highlights

  • Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
  • ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
  • Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology VC Funds in Europe investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 VC funds investing in Europe Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists